FDA Grants AP Status for Fosaprepitant Dimeglumine ANDA212143
The FDA has granted approval status (AP) for the ANDA212143 application for Fosaprepitant Dimeglumine submitted by Chia Tai Tianqing.
Therapeutic Area
Therapeutic area intelligence for Antiemetic with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.